Publications by authors named "Jedd Levine"

Claim this Profile
T
Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1.
Adrian Schwarzer, Matheus Oliveira, Marc-Jens Kleppa, Scott D Slattery, Andy Anantha, Jedd Levine

Mol Cancer Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications.
Ewan Hunter, Matthew Salter, Ryan Powell, Ann Dring, Tarun Naithani, Jedd Levine

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents" [Bioorg. Med. Chem. Lett. 27 (2017) 4471-4477].
Alan B Cooper, Stephane Ciblat, Gerald Shipps, Jedd Levine, Matthew Kostura

Bioorg Med Chem Lett· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Thiazol-2-yl-N-3-methyl-1H-pyrozole-5-carboxylic acid derivatives as antitumor agents.
Alan B Cooper, Stephane Ciblat, Gerald Shipps, Jedd Levine, Matthew Kostura

Bioorg Med Chem Lett· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis